Skip to main content
All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

TARPLIN, DOWNS & YOUNG, LLC filed a Q1 report for JAZZ PHARMACEUTICALS INC. on April 20, 2026, reporting $80,000 in lobbying income.

Lobbying for JAZZ PHARMACEUTICALS INC. · A specialty biopharmaceutical company

All filings by TARPLIN, DOWNS & YOUNG, LLC · Everything JAZZ PHARMACEUTICALS INC. has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Apr 20, 2026.
 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 2
  • RAISSA H DOWNS
    Previously held: Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
  • PARICK BRAERTON CARROLL
    Previously held: Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Regulation of botanical products Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing Expiring healthcare extenders Issues related to BIOSECURE

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem